Form 4: IN8BIO Director Emily Fairbairn Acquires Stock Options

Director Emily Fairbairn acquired stock options in IN8BIO, INC. on June 12, 2024.

Summary

• On June 12, 2024, Emily Fairbairn, a director of IN8BIO, INC., acquired stock options to purchase 33,650 shares of common stock at an exercise price of $1.47.
• The options vest in equal monthly installments starting July 12, 2024, with full vesting by the date of the company's next annual meeting of stockholders, contingent on continued service.
• Following the transaction, Fairbairn directly owns 33,650 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock option grants, which is neither particularly positive nor negative on its own.

Positives

• The acquisition of stock options by a director signals confidence in the company's future prospects.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders, such as directors and officers, transact in their company's securities. This filing indicates a grant of stock options to a director, which is a common practice for aligning management's interests with those of shareholders.

Stakeholder Impact

• The granting of stock options to a director can align their interests with those of shareholders, potentially incentivizing them to increase shareholder value.

Key Dates